Anthrax Antibody
Anthrax is a zoonotic disease caused by Bacillus anthracis; an encapsulated, facultatively anaerobic, gram-positive, rod-shaped bacteria that produces toxins (edema factor and lethal toxin). Sources of infection include soil and contaminated products from both domestic and wild animals. B. anthracis has ability to form resistant spores in response to extreme environmental conditions and can persist for long periods in terrestrial or aquatic environments. Spores become infectious upon contact with a host (human or animal) either by respiratory, gastrointestinal, or cutaneous exposure. Infected spores then become invasive bacteria that multiply and spread rapidly. Because of the sporulation capability anthrax could be potentially used as a bioterrorism agent and is therefore a reportable diagnosis in most states.
Based on exposure and infection, there are four types of anthrax:
Cutaneous anthrax, most common form of anthrax infection, is considered to be the least dangerous; Respiratory or inhalation anthrax is considered to be the deadliest form of anthrax; Gastrointestinal anthrax mostly acquired through food and it is a relatively rare form of infection and the last form of infection is through injection, which is very rare way of infection. Depending on the type of infection, symptoms typically develop within days or weeks of exposure but sometimes it can be delayed for months. Without appropriate treatment, all types of anthrax can cause systematic disease and death.
Diagnosis of anthrax can be make by several methods including culture and identified on blood agar, by antibody and antigen detection methods and by molecular methods. Culturing is the gold standard method for the identification of B. anthracis; however, the method is lengthy and subjective, and it depends on viability of the specimen. Antigen and antibody detection by immunoassay are also available, however, the sensitivity and specificity of these methods is low. Since the diagnosis of anthrax needs to be as rapidly as possible molecular methods using Real-time PCR are the method of choice as it can detect and genotype the pathogen a matter of hours. Skin testing with anthraxin is an alternative to in vitro methods for diagnosing anthrax within days of exposure and can detect 80% of cases within the first three days of disease. It is of limited value in patients with a prior history of anthrax infection as the test remains positive for decades after exposure.
- Diagnosis of Anthrax disease
- Screening for Bacillus anthracis exposure
Positive in:
- Anthrax
- Bacillus anthracis exposure
Not Detected (Negative)
Serum (SST tube).
Stability
- Ambient: 5 days
- Refrigerated: 7 days
- Frozen: 30 days
- N Engl J Med. 1999 Sep 9;341(11):815-26. [PMID: 10477781]
- Anal Bioanal Chem. 2006 Jan;384(1):73-84. [PMID: 16283259]
- J Microbiol Methods. 2010 Jul;82(1):1-10. [PMID: 20399814]
- Appl Biochem Biotechnol. 2015 Jun;176(4):957-77. [PMID: 2598713]
- Am J Respir Crit Care Med. 2011 Dec 15;184(12):1333-41. [PMID: 21852539]
- Chest. 1999 Nov;116(5):1369-76. [PMID: 1055910]
- JAMA. 2002 May 1;287(17):2236-52. [PMID: 11980524]
- Curr Opin Microbiol. 2011 Oct;14(5):532-43. [PMID: 21862392]
- JAMA. 2001 Nov 14;286(18):2226-32. [PMID: 11757528]